These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 32182519)
1. Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors. Moi D; Nocentini A; Deplano A; Osman SM; AlOthman ZA; Piras V; Balboni G; Supuran CT; Onnis V Bioorg Chem; 2020 May; 98():103728. PubMed ID: 32182519 [TBL] [Abstract][Full Text] [Related]
2. In-vitro and in-silico investigations of SLC-0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors. Sharma V; Vats L; Giovannuzzi S; Mohan B; Supuran CT; Sharma PK Arch Pharm (Weinheim); 2024 Aug; 357(8):e2400157. PubMed ID: 38713910 [TBL] [Abstract][Full Text] [Related]
3. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors. El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526 [TBL] [Abstract][Full Text] [Related]
4. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors. Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity. Congiu C; Onnis V; Deplano A; Balboni G; Dedeoglu N; Supuran CT Bioorg Med Chem Lett; 2015 Sep; 25(18):3850-3. PubMed ID: 26233435 [TBL] [Abstract][Full Text] [Related]
6. Fluorinated pyrrolidines and piperidines incorporating tertiary benzenesulfonamide moieties are selective carbonic anhydrase II inhibitors. Le Darz A; Mingot A; Bouazza F; Castelli U; Karam O; Tanc M; Supuran CT; Thibaudeau S J Enzyme Inhib Med Chem; 2015; 30(5):737-45. PubMed ID: 25431145 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and Carbonic Anhydrase I, II, IX, and XII Inhibition Studies with a Series of Cyclic Sulfonyl Guanidines. Abdoli M; Bonardi A; Supuran CT; Žalubovskis R ChemMedChem; 2024 Oct; 19(19):e202400197. PubMed ID: 38923747 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides. Abdoli M; Angeli A; Bozdag M; Carta F; Kakanejadifard A; Saeidian H; Supuran CT J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1071-1078. PubMed ID: 28753093 [TBL] [Abstract][Full Text] [Related]
9. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies. Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774 [TBL] [Abstract][Full Text] [Related]
10. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies. Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134 [TBL] [Abstract][Full Text] [Related]
11. New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: synthesis, in vitro biological evaluation, and molecular docking studies. Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Berrino E; Abdelsamie AS; El Diwani HI; Supuran CT Bioorg Med Chem; 2020 Mar; 28(5):115329. PubMed ID: 32007388 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors. Angeli A; Carta F; Bartolucci G; Supuran CT Bioorg Med Chem; 2017 Jul; 25(13):3567-3573. PubMed ID: 28522267 [TBL] [Abstract][Full Text] [Related]
13. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607 [TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567 [TBL] [Abstract][Full Text] [Related]
15. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies. Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095 [TBL] [Abstract][Full Text] [Related]
16. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment. El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463 [TBL] [Abstract][Full Text] [Related]
17. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action. Havránková E; Csöllei J; Vullo D; Garaj V; Pazdera P; Supuran CT Bioorg Chem; 2018 Apr; 77():25-37. PubMed ID: 29324250 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors. Kumar R; Vats L; Bua S; Supuran CT; Sharma PK Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII. Ibrahim DA; Lasheen DS; Zaky MY; Ibrahim AW; Vullo D; Ceruso M; Supuran CT; Abou El Ella DA Bioorg Med Chem; 2015 Aug; 23(15):4989-4999. PubMed ID: 26048024 [TBL] [Abstract][Full Text] [Related]
20. Development of novel organometallic sulfonamides with N-ethyl or N-methyl benzenesulfonamide units as potential human carbonic anhydrase I, II, IX and XII isoforms' inhibitors: Synthesis, biological evaluation and docking studies. Gallardo M; Arancibia R; Supuran CT; Nocentini A; Villaman D; Toro PM; Muñoz-Osses M; Mascayano C J Inorg Biochem; 2024 Nov; 260():112689. PubMed ID: 39121601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]